Novartis Pharmaceuticals
Novartis Pharmaceuticals is a division of the Swiss multinational pharmaceutical company Novartis, headquartered in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world, known for developing, manufacturing, and marketing a wide range of medications and vaccines. The company focuses on a variety of therapeutic areas, including oncology, neurology, immunology, and cardiology.
History[edit | edit source]
Novartis Pharmaceuticals was formed in 1996 through the merger of Ciba-Geigy and Sandoz, two Swiss companies with a long history in the pharmaceutical industry. The merger was aimed at creating synergies in the development and marketing of pharmaceutical products.
Products[edit | edit source]
Novartis Pharmaceuticals has developed several notable drugs, including:
- Gleevec (imatinib), used in the treatment of multiple cancers, most notably chronic myeloid leukemia.
- Cosentyx (secukinumab), for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis.
- Entresto (sacubitril/valsartan), for heart failure.
Research and Development[edit | edit source]
The company invests heavily in R&D, focusing on innovative therapies that address significant unmet medical needs. Novartis Pharmaceuticals has been involved in the development of gene therapies and personalized medicine, leveraging cutting-edge technologies such as CRISPR and CAR-T cell therapy.
Controversies[edit | edit source]
Novartis Pharmaceuticals has faced several controversies, including issues related to pricing and patenting of medications. The company has been involved in legal disputes over drug patents and has faced criticism over the high cost of some of its medications.
Corporate Social Responsibility[edit | edit source]
Novartis Pharmaceuticals engages in various corporate social responsibility (CSR) initiatives, focusing on access to healthcare, patient advocacy, and sustainable business practices. The company has programs aimed at improving access to medications in developing countries.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
